PMC:7454258 / 199907-201328 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T1","span":{"begin":1112,"end":1118},"obj":"Body_part"},{"id":"T2","span":{"begin":1303,"end":1312},"obj":"Body_part"},{"id":"T3","span":{"begin":1308,"end":1312},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"fma_id","subj":"T1","obj":"http://purl.org/sig/ont/fma/fma84116"},{"id":"A2","pred":"fma_id","subj":"T2","obj":"http://purl.org/sig/ont/fma/fma63368"},{"id":"A3","pred":"fma_id","subj":"T3","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"Trans-NIH initiatives are efforts to promote collaborative research across NIH in a particular area of science. These initiatives can originate from the NIH Director; NIH institutes, centers, or offices; or Congress. Some of these initiatives engage with external stakeholders such as businesses and nonprofit foundations. The funding, leadership, and structures for trans-NIH initiatives tend to vary. Generally, trans-NIH programs utilize the same mechanisms of grant funding that NIH currently offers: research grants (R series), career development awards (K series), research training and fellowships (T \u0026 F series), program project/center grants (P series), and resource grants (various series) (333). NIH currently supports a variety of broad-reaching programs that are trans-NIH in nature; examples include Biomedical Information Science and Technology Institute (BISTI), NIH Blueprint for Neuroscience Research, Research Supplements to Promote Diversity in Health-Related Research, Administrative Supplements to Existing NIH Grants and Cooperative Agreements, New and Early Stage Investigators Policies, Genome-Wide Association Studies, NIH Common Fund, NIH Basic Behavioral and Social Science Research Opportunity Network (OppNet), Presidential Early Career Award for Scientists and Engineers, Stem Cell Information (PECASE), and the Trans-NIH Countermeasures Against Chemical Threats (CounterACT) program (333)."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T3","span":{"begin":82,"end":83},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T4","span":{"begin":730,"end":731},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T5","span":{"begin":1303,"end":1312},"obj":"http://purl.obolibrary.org/obo/CL_0000034"}],"text":"Trans-NIH initiatives are efforts to promote collaborative research across NIH in a particular area of science. These initiatives can originate from the NIH Director; NIH institutes, centers, or offices; or Congress. Some of these initiatives engage with external stakeholders such as businesses and nonprofit foundations. The funding, leadership, and structures for trans-NIH initiatives tend to vary. Generally, trans-NIH programs utilize the same mechanisms of grant funding that NIH currently offers: research grants (R series), career development awards (K series), research training and fellowships (T \u0026 F series), program project/center grants (P series), and resource grants (various series) (333). NIH currently supports a variety of broad-reaching programs that are trans-NIH in nature; examples include Biomedical Information Science and Technology Institute (BISTI), NIH Blueprint for Neuroscience Research, Research Supplements to Promote Diversity in Health-Related Research, Administrative Supplements to Existing NIH Grants and Cooperative Agreements, New and Early Stage Investigators Policies, Genome-Wide Association Studies, NIH Common Fund, NIH Basic Behavioral and Social Science Research Opportunity Network (OppNet), Presidential Early Career Award for Scientists and Engineers, Stem Cell Information (PECASE), and the Trans-NIH Countermeasures Against Chemical Threats (CounterACT) program (333)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T1098","span":{"begin":0,"end":111},"obj":"Sentence"},{"id":"T1099","span":{"begin":112,"end":216},"obj":"Sentence"},{"id":"T1100","span":{"begin":217,"end":322},"obj":"Sentence"},{"id":"T1101","span":{"begin":323,"end":402},"obj":"Sentence"},{"id":"T1102","span":{"begin":403,"end":706},"obj":"Sentence"},{"id":"T1103","span":{"begin":707,"end":1421},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Trans-NIH initiatives are efforts to promote collaborative research across NIH in a particular area of science. These initiatives can originate from the NIH Director; NIH institutes, centers, or offices; or Congress. Some of these initiatives engage with external stakeholders such as businesses and nonprofit foundations. The funding, leadership, and structures for trans-NIH initiatives tend to vary. Generally, trans-NIH programs utilize the same mechanisms of grant funding that NIH currently offers: research grants (R series), career development awards (K series), research training and fellowships (T \u0026 F series), program project/center grants (P series), and resource grants (various series) (333). NIH currently supports a variety of broad-reaching programs that are trans-NIH in nature; examples include Biomedical Information Science and Technology Institute (BISTI), NIH Blueprint for Neuroscience Research, Research Supplements to Promote Diversity in Health-Related Research, Administrative Supplements to Existing NIH Grants and Cooperative Agreements, New and Early Stage Investigators Policies, Genome-Wide Association Studies, NIH Common Fund, NIH Basic Behavioral and Social Science Research Opportunity Network (OppNet), Presidential Early Career Award for Scientists and Engineers, Stem Cell Information (PECASE), and the Trans-NIH Countermeasures Against Chemical Threats (CounterACT) program (333)."}